Surgical Science Sweden AB (publ)

OM:SUS Stok Raporu

Piyasa değeri: SEK 6.5b

Surgical Science Sweden Yönetim

Yönetim kriter kontrolleri 2/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Tom Englund

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresiless than a year
CEO sahipliğin/a
Yönetim ortalama görev süresi3.8yrs
Yönetim Kurulu ortalama görev süresi3.5yrs

Son yönetim güncellemeleri

Recent updates

Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Aug 25
Surgical Science Sweden AB (publ) Just Missed EPS By 22%: Here's What Analysts Think Will Happen Next

Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 21
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Apr 16
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors

Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Mar 17
Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump

Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 24
Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts

Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Nov 29
Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?

Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Oct 07
Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?

Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

Aug 17
Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?

With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

Jun 20
With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case

A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

May 17
A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Dec 27
Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate

Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Dec 06
Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?

Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Sep 08
Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?

We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Aug 23
We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease

Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

May 26
Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless

Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

Apr 29
Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching

An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Feb 20
An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jan 11
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Dec 15
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Sep 16
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Jul 05
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Jun 08
Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Mar 23
Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?

Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Mar 02
Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)

Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Feb 09
Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?

Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?

Jan 01
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?

What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?

Dec 14
What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?

Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

Nov 26
Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?

CEO

Tom Englund (48 yo)

less than a year

Görev süresi

Mr. Tom Englund is Chief Executive Officer of Surgical Science Sweden AB (publ) from October 1, 2024. Mr. Englund served as Division Chief Executive Officer of Tobii Pro and Deputy Chief Executive Officer...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Gisli Hennermark
Advisor & Directorless than a yearSEK 5.83m0.67%
SEK 43.8m
Tom Englund
Chief Executive Officerless than a yearVeri yokVeri yok
Anders Larsson
Co-Founder & CTO5.8yrsVeri yok0.059%
SEK 3.8m
Anna Ahlberg
Chief Financial Officer6.8yrsVeri yok0.047%
SEK 3.1m
Boaz Tal
Chief Operating Officer3.8yrsVeri yok0.036%
SEK 2.4m
Martin Jansson
Head of Global Sales3.8yrsVeri yokVeri yok
Inbal Mazor-Badichi
Executive Vice President of Products & Marketing3yrsVeri yok0.036%
SEK 2.4m
Daniel Evestedt
Head of Development5yrsVeri yokVeri yok
Jeffrey Berkley
Chief Innovation Officer3.8yrsVeri yokVeri yok
Ran Bronstein
President of Research & Development2.8yrsVeri yok0.042%
SEK 2.8m
Doron Zilberman
Executive Vice President of International Sales & Educational Productsno dataVeri yok0.010%
SEK 658.5k
Niclas Olsson
Executive Vice President of Industry & OEM2.5yrsVeri yokVeri yok

3.8yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim: SUS's management team is considered experienced (3.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Gisli Hennermark
Advisor & Directorless than a yearSEK 5.83m0.67%
SEK 43.8m
Roland Bengtsson
Chairman of the Board19.8yrsVeri yok11.74%
SEK 766.4m
Jan Bengtsson
Director19.8yrsVeri yok13.99%
SEK 913.0m
Thomas Eklund
Independent Director7.8yrsVeri yok0.0020%
SEK 127.9k
Asa Bredin
Independent Director1.5yrsVeri yok0.00069%
SEK 45.0k
Elisabeth Hansson
Independent Director3.5yrsVeri yok0.0026%
SEK 166.4k
Henrik Falconer
Independent Director3.5yrsVeri yok0.0020%
SEK 127.9k

3.5yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SUS's board of directors are considered experienced (3.5 years average tenure).